Effects of Vedolizumab in Japanese Patients With Crohn’s Disease: A Prospective, Multicenter, Randomized, Placebo-Controlled Phase 3 Trial With Exploratory Analyses
Journal of Gastroenterology - Germany
doi 10.1007/s00535-019-01647-w
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 13, 2019
Authors
Publisher
Springer Science and Business Media LLC